Hybrid PET/CT in Cancer Patients
Not Applicable
Completed
- Conditions
- Cancer
- Registration Number
- NCT00396916
- Lead Sponsor
- Rambam Health Care Campus
- Brief Summary
The purpose of the present study is to assess the role of hybrid PET/CT imaging diagnosis of active malignancy in cancer patients with rising tumor markers after treatment and in the diagnosis of primary tumor in patients with metastatic cancer of unknown origin. The clinical impact of PET/CT in the management and treatment of these two groups of cancer patients will be evaluated
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
- Cancer patients in complete remission after treatment, with serial elevation of serum tumor markers and negative CT or other conventional imaging test.
- Patients with newly diagnosed metastatic cancer with unknown primary tumor
- Glucose levels below 150-200
- Patient signed informed consent
Exclusion Criteria
- Pregnant or lactating women
- Patient unable or not willing to tolerate the test until its completion
- One or more of the inclusion criteria is not fulfilled
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method the impact of the imaging modality on patient management
- Secondary Outcome Measures
Name Time Method the impact of the imaging modality on patient management
Trial Locations
- Locations (1)
Rambam Medical Center
🇮🇱Haifa, Israel